Medical Oncology

, 30:502 | Cite as

Secondary mucosa-associated lymphoid tissue (MALT) lymphoma of the colon

Short Communication

Abstract

Mucosa-associated lymphoid tissue (MALT)-type lymphomas most commonly occur in the stomach and have been associated with Helicobacter pylori infection. However, MALT-type lymphoma of the colon is a rare entity. It commonly manifests with symptoms of weight loss, low-grade fever, constipation, melena, and hematochezia. Unlike gastric lymphoma, it is difficult to detect MALT-type lymphoma of the colon by imaging. Colonoscopy may reveal lesions whose biopsy most commonly shows abundant B lymphocytes. There is no universal immunohistochemistry profile for MALT-type lymphoma but CD 20 staining is commonly seen. Trisomies and translocations have been described and their presence has been correlated with treatment response. Due to the rarity of colonic MALT-type lymphoma, no standard guidelines are available for its management. It often occurs individually and rarely occurs simultaneously with concurrent colon adenocarcinoma. This case report describes the presentation and clinical course of a secondary MALT-type lymphoma in a patient who underwent colectomy for a prior colon adenocarcinoma.

Keywords

MALT Secondary Colon Adenocarcinoma Lymphoma 

References

  1. 1.
    Sipos F, Muzes G. Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer? World J Gastroenterol. 2011;17(13):1666–73. doi:10.3748/wjg.v17.i13.1666.PubMedCrossRefGoogle Scholar
  2. 2.
    Featherstone C. M cells: portals to the mucosal immune system. Lancet. 1997;350(9086):1230. doi:10.1016/S0140-6736(05)63467-8.PubMedCrossRefGoogle Scholar
  3. 3.
    Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52(8):1410–6.PubMedCrossRefGoogle Scholar
  4. 4.
    d’Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen MK, Andersen E, Pedersen NT, Mortensen LS. Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish lymphoma study group. J Clin Oncol. 1994;12(8):1673–84.PubMedGoogle Scholar
  5. 5.
    Stolte M, Bayerdorffer E, Morgner A, Alpen B, Wundisch T, Thiede C, Neubauer A (2002) Helicobacter and gastric MALT lymphoma. Gut 50 Suppl 3:III19–24.Google Scholar
  6. 6.
    Wundisch T, Dieckhoff P, Greene B, Thiede C, Wilhelm C, Stolte M, Neubauer A (2012) Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology 143 (4):936-942; quiz e913–e934. doi:10.1053/j.gastro.2012.06.035.Google Scholar
  7. 7.
    Auner HW, Beham-Schmid C, Lindner G, Fickert P, Linkesch W, Sill H. Successful nonsurgical treatment of primary mucosa-associated lymphoid tissue lymphoma of colon presenting with multiple polypoid lesions. Am J Gastroenterol. 2000;95(9):2387–9. doi:10.1111/j.1572-0241.2000.02343.x.PubMedCrossRefGoogle Scholar
  8. 8.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C. Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer. 2008;127(12):2893–917. doi:10.1002/ijc.25516.CrossRefGoogle Scholar
  9. 9.
    Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19(12):1992–9. doi:10.1093/annonc/mdn525.PubMedCrossRefGoogle Scholar
  10. 10.
    Ahlawat S, Kanber Y, Charabaty-Pishvaian A, Ozdemirli M, Cohen P, Benjamin S, Haddad N. Primary mucosa-associated lymphoid tissue (MALT) lymphoma occurring in the rectum: a case report and review of the literature. South Med J. 2006;99(12):1378–84.PubMedCrossRefGoogle Scholar
  11. 11.
    Arnold IC, Hitzler I, Engler D, Oertli M, Agger EM, Muller A. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia. J Immunol. 2011;186(11):6165–72. doi:10.4049/jimmunol.1003472.PubMedCrossRefGoogle Scholar
  12. 12.
    Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342(8871):575–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Dohden K, Kaizaki Y, Hosokawa O, Hayashi H, Hattori M. Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case. Dis Colon Rectum. 2004;47(9):1544–6. doi:10.1007/s10350-004-0575-2.PubMedCrossRefGoogle Scholar
  14. 14.
    Takenaka R, Tomoda J, Sakata T, Ichiba T, Motoi M, Mizuno M, Tsuji T. Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol. 2000;15(3):331–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Jezersek Novakovic B, Vovk M, Juznic Setina T. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003. Ann Hematol. 2006;85(12):849–56. doi:10.1007/s00277-006-0172-7.PubMedCrossRefGoogle Scholar
  16. 16.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S (2008) Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Am J Gastroenterol 103 (1):62–70. doi:10.1111/j.1572-0241.2007.01521.x.
  17. 17.
    Fischbach W. Long-term follow-up of gastric lymphoma after stomach conserving treatment. Best Pract Res Clin Gastroenterol. 2010;24(1):71–7. doi:10.1016/j.bpg.2009.12.005.PubMedCrossRefGoogle Scholar
  18. 18.
    Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2005;23(26):6370–8. doi:10.1200/JCO.2005.05.011.PubMedCrossRefGoogle Scholar
  19. 19.
    Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J Gastrointest Oncol. 2012;3(3):209–25. doi:10.3978/j.issn.2078-6891.2012.024.PubMedGoogle Scholar
  20. 20.
    Kobayashi T, Takahashi N, Hagiwara Y, Tamaru J, Kayano H, Jin-nai I, Bessho M, Niitsu N. Successful radiotherapy in a patient with primary rectal mucosa-associated lymphoid tissue lymphoma without the API2-MALT1 fusion gene: a case report and review of the literature. Leuk Res. 2008;32(1):173–5. doi:10.1016/j.leukres.2007.04.017.PubMedCrossRefGoogle Scholar
  21. 21.
    Amouri A, Chtourou L, Mnif L, Mdhaffar M, Abid M, Ayedi L, Daoud J, Elloumi M, Boudawara T, Tahri N. MALT lymphoma of the rectum: a case report treated by radiotherapy. Cancer Radiother. 2009;13(1):61–4. doi:10.1016/j.canrad.2008.11.001.PubMedCrossRefGoogle Scholar
  22. 22.
    Sahasrabudhe N, Khirwadkar N, Prescott R. Synchronous adenocarcinoma and marginal zone B-cell lymphoma of the colon: a case report. Diagn Histopathol. 2009;15(6):318–22.CrossRefGoogle Scholar
  23. 23.
    Argyropoulos T, Foukas P, Kefala M, Xylardistos P, Papageorgiou S, Machairas N, Boltetsou E, Machairas A, Panayiotides IG. Simultaneous occurrence of colonic adenocarcinoma and MALT lymphoma: a series of three cases. World J Gastrointest Oncol. 2012;4(4):89–93. doi:10.4251/wjgo.v4.i4.89.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Internal Medicine, Harvard Medical School, Massachusetts General HospitalHarvard UniversityBostonUSA

Personalised recommendations